Cart
sales@molnova.com
HMN-154
CAS No. 173528-92-2
HMN-154( HMN-154; HMN 154; HMN154 )
Catalog No. M17368 CAS No. 173528-92-2
HMN-154 is a novel benzenesulfonamide anticancer compound.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500mg | Get Quote | In Stock |
|
| 250mg | Get Quote | In Stock |
|
| 25mg | 591 | In Stock |
|
| 10mg | 461 | In Stock |
|
| 5mg | 303 | In Stock |
|
| 2mg | 145 | In Stock |
|
Biological Information
-
Product NameHMN-154
-
NoteResearch use only, not for human use.
-
Brief DescriptionHMN-154 is a novel benzenesulfonamide anticancer compound.
-
DescriptionHMN-154 is a benzenesulfonamide anticancer agent. HMN-154 inhibits DNA binding of NF-Y to the human major histocompatibility complex class II human leukocyte antigen DRA Y-box sequence in a dose-dependent manner.
-
SynonymsHMN-154; HMN 154; HMN154
-
PathwayTyrosine Kinase
-
TargetTAM Receptor
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number173528-92-2
-
Formula Weight366.44
-
Molecular FormulaC20H18N2O3S
-
Purity98%
-
Solubility——
-
SMILESc1(c(cccc1)/C=C/c1ccncc1)NS(=O)(=O)c1ccc(cc1)OC
-
Chemical Name(E)-4-(2-(2-(N-(4-Methoxybenzenesulfonyl)amino)phenyl)ethenyl)pyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tanaka H., et al. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol Pharmacol. 1999 Feb;55(2):356-63.
molnova catalog
related products
-
Glesatinib hydrochlo...
Glesatinib (MGCD-265) is a tyrosine kinase inhibitor that potently and selectively inhibits Met and Axl kinase.
-
S49076
S49076 is a potent, ATP-competitive tyrosine kinase inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 of <20 nM.
-
TP0903
TP-0903 is a potent and selective Axl kinase inhibitor with IC50 of 27 nM.
